From Corestem to Yuhan: Cellbion Eyes Fast-Track Path for Lu-177-DGUL 유진희 2025.08.27 오전 08:27 ‘Keytruda SC’ FDA Approval…Obesity Drug Battle in Europe[Monthly K-bio Pulse] 김새미 2025.08.27 오전 10:30 EnsolBio Plunges on Phase 3 Failure…Curiox Jumps on BEP Hopes[K-Bio Pulse] 나은경 2025.08.05 오전 08:30 Yuhan Jumps on Leclaza Sales; Genexine, KUKJEON Hit Limits[K-Bio Pulse] 김새미 2025.07.18 오전 07:30 유한양행, 정기주총서 주당 400원 현금배당 결의 석지헌 2023.03.23 오후 04:20 Oscotec Gains on Lazertinib UK Approval [K-Bio Pulse] 김지완 2025.03.10 오전 10:16 ABL Bio Shares Surge on GSK Licensing Deal [K-Bio Pulse] 김진수 2025.04.08 오전 07:58 HLB Panagene Aims for 50% Global Sales in 3 Years 석지헌 2025.04.29 오후 04:34 Selbion Up 2 Days, Eyes Lekraza Upside[[K-Bio Pulse] 석지헌 2025.07.25 오전 08:30 Korean Delegation Steals Spotlight at BIO USA 2025 김승권 2025.06.20 오후 04:02 더 보기 로딩중..
Yuhan
Yuhan
![‘Keytruda SC’ FDA Approval…Obesity Drug Battle in Europe[Monthly K-bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/08/PS25082700487b.jpg)
![EnsolBio Plunges on Phase 3 Failure…Curiox Jumps on BEP Hopes[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/08/PS25080500376b.jpg)
![Yuhan Jumps on Leclaza Sales; Genexine, KUKJEON Hit Limits[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/07/PS25071800234b.jpg)
![Oscotec Gains on Lazertinib UK Approval [K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25031000464b.jpg)
![ABL Bio Shares Surge on GSK Licensing Deal [K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/04/PS25040800208b.jpg)
![Selbion Up 2 Days, Eyes Lekraza Upside[[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/07/PS25072500367b.jpg)
